Back to Journals » Vascular Health and Risk Management » Volume 8

Diagnosis of carotid artery stenosis with oculopneumoplethysmography alone and in combination with MRA

Authors Elias RM, Wald JT, Kallmes DF

Received 15 June 2012

Accepted for publication 23 July 2012

Published 23 November 2012 Volume 2012:8 Pages 631—639

DOI https://doi.org/10.2147/VHRM.S35041

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Richard M Elias,1 John T Wald,2 David F Kallmes2

1Department of Internal Medicine, 2Department of Radiology, Mayo Clinic, Rochester, MN, USA

Background: The purpose of this study was to assess the accuracy of oculopneumoplethysmography (OPG) for the diagnosis of carotid artery stenosis both alone and in conjunction with carotid magnetic resonance angiography (MRA).
Methods: This retrospective study reviewed patients who had undergone both OPG and digital subtraction angiography (DSA, 90 patients, 174 vessels) within two weeks to determine the accuracy of OPG with DSA as the reference standard for the detection of carotid artery stenosis. Three carotid artery stenosis thresholds (≥50%, ≥70%, ≥80%) were analyzed. The accuracy of the combination of OPG and MRA was analyzed in a subset of patients who underwent OPG and MRA and DSA (53 patients, 94 vessels).
Results: The sensitivity and negative predictive value of OPG increased with higher-degree carotid artery stenoses, and for lesions ≥ 80%, these values were 85.3% and 94.2%, respectively. Specificity and positive predictive values were lower at all thresholds, and were 72.9% and 49.3%, respectively, at the ≥80% stenosis threshold. When OPG and MRA were concordant, the sensitivity and specificity for carotid artery stenoses ≥ 80% were 91.0% and 97.8%, respectively. OPG correctly identified 71.4% of false-positive and 80.0% of false-negative magnetic resonance angiographies for that degree of carotid artery stenosis.
Conclusion: OPG appears to be an accurate rule-out test for hemodynamically significant carotid artery stenosis. OPG augments the accuracy of MRA for detection of carotid artery disease.

Keywords: oculopneumoplethysmography, carotid artery stenosis, magnetic resonance angiography, diagnosis, stroke

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J

Therapeutics and Clinical Risk Management 2015, 11:1853-1861

Published Date: 17 December 2015

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation

Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG

Vascular Health and Risk Management 2014, 10:425-434

Published Date: 17 July 2014

Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease

Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlböck M, Uhl M, Köhler-Vallant B, Strametz-Juranek J

Vascular Health and Risk Management 2014, 10:311-317

Published Date: 13 May 2014

Visceral obesity is not an independent risk factor of mortality in subjects over 65 years

Thomas F, Pannier B, Benetos A, Vischer UM

Vascular Health and Risk Management 2013, 9:739-745

Published Date: 22 November 2013

Rivaroxaban in atrial fibrillation

Giorgi MA, Miguel LS

Vascular Health and Risk Management 2012, 8:525-531

Published Date: 30 August 2012